Trevi Therapeutics Inc

Small-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$14.26

-0.40 (-2.73%)

As of May 9, 1:34 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 17 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +53.8% upside

Low Target $18.04

Average Target $21.93

High Target $33.12

Current Price $14.26

Current
$14.26

Target
$21.93

$18.04 $21.93 avg $33.12

Scenario Analysis

Bear Case

$18.04

26.5%

Low target

Base Case

$21.93

+53.8%

Avg target

Bull Case

$33.12

+132.3%

High target

Risk/Reward

5.0x

Highly favorable

Price in Context

52-Week High

$16.12

-11.5% from high

52-Week Low

$5.38

+165.1% from low

Target vs 52W High

$21.93

+36.0% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
RDY Dr. Reddy's Laboratories	Hold	45	51%	—	+0.0%
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+40.3%
JNJ Johnson & Johnson	Buy	32	63%	$299.55	+35.3%
MRK Merck & Co. Inc.	Buy	35	71%	$159.27	+43.0%
PFE Pfizer Inc.	Hold	36	44%	$33.90	+32.0%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+210.7%
ZTS Zoetis Inc	Buy	25	60%	$209.87	+153.4%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-28.6%